
21/07/2025
Dr. Joanne Lee shared how we treat first-line DLBCL in Singapore at the 2025 International Conference on Translational Medicine and Innovation of Blood Diseases in Shanghai.
She spoke on:
🔹 PET-adapted treatment and dose reduced therapy for localized disease
🔹 Pola-R-CHP for high-risk IPI
🔹 DA-R-EPOCH for double-hit lymphoma
🔹 Tailored regimens for elderly, cardiac, and immunocompromised patients
🔹 Evolving CNS prophylaxis and radiotherapy practices
A deep dive into how global evidence meets local care, with patient-centred decisions and national frameworks at the core.